WWW - Posts tagged GENZ at BloggingStocks

GENZ posts

Closing Bell: A Double From Lows (CAGC, CMCSA, DELL, DSCO, FDO, GENZ, SNY)

Posted Feb 16th 2011 4:20PM by Jon Ogg (RSS feed)
Filed under: Dell (DELL), Comcast Cl'A' (CMCSA), Family Dollar Stores (FDO), Genzyme (GENZ)

The FOMC Minutes offered a slight economic upgrade today. A large draw in oil inventories and word that Iran was sending two warships through the Suez canal to go to the Mediterranean spooked investors for a bit. The S&P is now up 100% from the lows of March 2009.

Here were today's unofficial closing bell levels:

Dow Jones 12,288.17 +61.53 (0.50%)
S&P 500 1,336.32 +8.31 (0.63%)
Nasdaq 2,825.56 +21.21 (0.76%)

Continue reading Closing Bell: A Double From Lows (CAGC, CMCSA, DELL, DSCO, FDO, GENZ, SNY)

U.S. Stock Futures Up After Dell Reports Upbeat Earnings

Posted Feb 16th 2011 8:30AM by Jason Raznick (RSS feed)
Filed under: Before the Bell, Earnings Reports, Deals, Dell (DELL), Family Dollar Stores (FDO), Genzyme (GENZ)

U.S. stock futures are higher Wednesday morning as Sanofi-Aventis (SNY) agreed to purchase Genzyme (GENZ) and Dell (DELL) reported upbeat quarterly earnings.

Futures on the Dow Jones Industrial Average gained 30 points to 12,232 and S&P 500 futures rose 4.20 points to 1,330.50. Nasdaq 100 futures gained 5.50 points to 2,387.

U.S. stocks closed lower Tuesday, with the Dow Jones Industrial Average dropping 0.34% to close at 12,227.

Continue reading U.S. Stock Futures Up After Dell Reports Upbeat Earnings

Closing Bell: Getting Back On Track (AMB, PLD, XOM, INTC, AMD, GENZ, EGPT, CCME)

Posted Jan 31st 2011 4:00PM by Jon Ogg (RSS feed)
Filed under: Intel (INTC), Exxon Mobil (XOM)

This week got off to a good start considering that last Friday was a rough day in the market due to the geopolitics of the day. Egypt is not getting much better and the economy has come to a stop as no one is back at work yet. Still, things aren't getting worse. This offered some stability to the region. Brent Sea crude hit $100 per barrel today. Data from the PMI showed that inflation at the wholesale level continues to firm, while spending seems to outstrip income again.

Here were today's unofficial closing bell levels:

Dow Jones 11,891.93 +68.23 (0.58%)
S&P 500 1,286.12 +9.78 (0.77%)
Nasdaq 2,700.08 +13.19 (0.49%)

Top Analyst upgrades and downgrades

Continue reading Closing Bell: Getting Back On Track (AMB, PLD, XOM, INTC, AMD, GENZ, EGPT, CCME)

Closing Bell: Dollar and Terror Kick Start the Week Off Weak (ISLN, MSFT, GENZ, SNY, AXP, ACTL, MSCC, PFE)

Posted Oct 4th 2010 4:10PM by Jon Ogg (RSS feed)
Filed under: Microsoft (MSFT), Pfizer (PFE), American Express (AXP)

Stocks started the week off in the red on a key tech downgrade, and as the U.S. dollar rose against some key currencies. Frankly, today felt like a day where the real answer was "more sellers than buyers" over a key catalyst, even considering a EU terror alert. The end of the TARP program marked more sentiment than any real event.

Here were the unofficial closing bell levels:

Dow Jones 10,751.27 -78.41 (-0.72%)
S&P 500 1,137.03 -9.21 (-0.80%)
Nasdaq 2,344.52 -26.23 (-1.11%)

Top Analyst Calls
Best & Worst DJIA Stocks

Continue reading Closing Bell: Dollar and Terror Kick Start the Week Off Weak (ISLN, MSFT, GENZ, SNY, AXP, ACTL, MSCC, PFE)

Options Update: General Mills Calls Active on Elevated Volatility

Posted Sep 25th 2010 8:40AM by Paul Foster (RSS feed)
Filed under: General Mills (GIS), Options

General Mills (GIS) option was active on call volume of 88K contracts, compared to put volume of 8K contracts. October put option implied volatility is at 28, January is at 25, above its 26-week average of 21, according to Track Data. The active call volume suggests traders taking positions for price movement.

Stocks with implied volatility below index mean range: Genzyme (GENZ), Potash (POT) and Chelsea Therapeutic (CHTP), according to IVolatility.

Options Update is by Stock Specialist Paul Foster of theflyonthewall.com.

Closing Bell: Traders Put The Risk Back On (MSFT, LNG, OXGN, ARST, HPQ, GENZ, SNY, PCG)

Posted Sep 13th 2010 5:20PM by Jon Ogg (RSS feed)
Filed under: Microsoft (MSFT), PG and E Corporation (PCG)

Today was another up day, mostly thanks to the new Basel III banking accords showing that most banks are actually not in need of fresh capital any time in the immediate future. We also saw Warren Buffett refute that there is a double-dip recession and we also had a slightly less-atrocious August Treasury deficit than expected. This was a day where traders began putting back on the risk trade.

Here were today's closing bell levels:

DJIA
S&P500
NASDAQ

Continue reading Closing Bell: Traders Put The Risk Back On (MSFT, LNG, OXGN, ARST, HPQ, GENZ, SNY, PCG)

Lab Corp Buys Genzyme Genetics Unit

Posted Sep 13th 2010 1:20PM by Brent Archer (RSS feed)
Filed under: Major Movement, Deals, Bad News, Options, Technical Analysis, Genzyme (GENZ)

LabCorp (LH - option chain) stock is trading lower today after the company announced that it has agreed to purchase Genzyme's (GENZ) Genzyme Genetics unit in a $925 million all-cash deal. The price was higher than some analysts expected and is expected to negatively impact LH's earnings by 0.25 over the next year, which is sending LH stock lower today. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on LH.

This morning, LH opened at $75.55 So far today the stock has hit a high of $75.99 and a low of $73.93. As of 12:25, LH is trading at $73.73 down $2.93 (-2.9%). The chart for LH looks bullish and S&P gives LH a positive 4 STARS (out of 5) buy ranking.

Continue reading Lab Corp Buys Genzyme Genetics Unit

Closing Bell: Double Dip Fears Easing Somewhat (MW, GENZ, SKX, USO, TBT, EMMS)

Posted Sep 9th 2010 4:00PM by Jon Ogg (RSS feed)
Filed under: Genzyme (GENZ)

A narrower trade deficit and a lower report of weekly jobless claims did not keep the market endlessly higher again today despite the notion that the markets were at least up. The biggest sector news was an almost endless biotech bonanza of analyst upgrades and a plethora of drug news.

Here were today's unofficial closing bell levels:

Dow Jones 10,415.24 +28.23 (0.27%)
S&P 500 1,104.21 +5.34 (0.49%)
Nasdaq 2,236.20 +7.33 (0.33%)

Top Analyst Calls
BioHealth Business Daily

Continue reading Closing Bell: Double Dip Fears Easing Somewhat (MW, GENZ, SKX, USO, TBT, EMMS)

Analyst Calls: AMGN, CAVM, COCO, GENZ, GILD, ICE, PWRD, SSCC, VMW ...

Posted Aug 16th 2010 11:30AM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Analyst Initiations, Gilead Sciences (GILD), Genzyme (GENZ)

Analyst Upgrades

Deutsche Bank upgraded Smurfit-Stone (SSCC) to buy from hold after raising its estimates for containerboard names and upped its target for shares to $28 from $22. The firm also raised its price target for International Paper (IP) to $38 from $32, for Packaging Corp. (PKG) to $33 from $28, for Temple-Inland (TIN) to $31 from $28, for Greif (GEF) to $67 from $65, and for Rock-Tenn (RKT) to $70 from $65. All stocks are buy rated.
ThinkEquity upgraded VMware (VMW) to buy from hold and has a $90 price target on the stock. The firm expects VMware to benefit from increased virtual infrastructure adoption and improving vSphere solutions.
Needham upgraded Cavium Networks (CAVM) to strong buy from buy, citing the recent pullback in shares following Cisco's (CSCO) cautious commentary. The firm has a $37 target on the stock.
Intercontinental Exchange (ICE) was upgraded to outperform from neutral at Credit Suisse.
MedAssets (MDAS) was upgraded to buy from hold at Auriga.
Brookfield Properties (BPO) was upgraded to buy from hold at Citigroup.

Continue reading Analyst Calls: AMGN, CAVM, COCO, GENZ, GILD, ICE, PWRD, SSCC, VMW ...

Analyst Calls: ADSK, ATK, BCS, GENZ, H, ROCK, SFD, UL, VIA ...

Posted Aug 6th 2010 12:00PM by Eric Buscemi (RSS feed)
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, Viacom (VIA), Smithfield Foods (SFD), Analyst Initiations, Barclays plc ADS (BCS), Unilever ADR (UL), Genzyme (GENZ)

Analyst Upgrades

Credit Suisse upgraded Alliant Techsystems (ATK) to outperform from neutral following the company's increased FY11 guidance. The firm has an $85 target on the stock.
FBR Capital upgraded Hyatt Hotels (H) to market perform from underperform following the company's Q2 results. The firm raised its target for shares to $44 from $38.
BB&T upgraded to Smithfield Foods (SFD) to buy from hold, citing tighter supplies, strong pork prices and improving export demand. The firm has a $19 target on the stock.
Holly (HOC) was upgraded to outperform from market perform at BMO Capital.
Cogent Communications (CCOI) was upgraded to outperform from neutral at Cowen.
Catalyst Health (CHSI) was upgraded to overweight from equal weight at First Analysis.

Continue reading Analyst Calls: ADSK, ATK, BCS, GENZ, H, ROCK, SFD, UL, VIA ...

Closing Bell: No Double-Dip Recession Here (ASF, BAC, CRL, GENZ, HUM, RIMM)

Posted Aug 2nd 2010 4:20PM by Jon Ogg (RSS feed)
Filed under: Bank of America (BAC), Research in Motion (RIMM)

Today started out strong and ended up even stronger with triple-digit DJIA gains. The reports from ISM showed no manufacturing recession and actually showed more employment improvements. This was on the heels of a strong Chinese auto figure and on all major indexes outside of the US trading higher. The S&P 500 even got back above its 200-day moving average.

Here were today's unofficial closing bell readings:

Dow Jones 10,674.38 +208.44 (1.99%)
S&P 500 1,125.86 +24.26 (2.20%)
Nasdaq 2,295.36 +40.66 (1.80%)

Continue reading Closing Bell: No Double-Dip Recession Here (ASF, BAC, CRL, GENZ, HUM, RIMM)

Genzyme Lifted by Takeover Speculation

Posted Jul 29th 2010 1:30PM by Brent Archer (RSS feed)
Filed under: Major Movement, Deals, Good news, Rumors, Options, Technical Analysis, Genzyme (GENZ)

Genzyme (GENZ - option chain) shares are rising today on a report in the Wall Street Journal which says that Sanofi-Aventis SA (SNY) could make a formal takeover offer to GENZ's board that could be worth about $20 billion. SNY declined to comment on the report. If you think that the stock won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on GENZ.

GENZ opened this morning at $70.31. So far today the stock has hit a low of $69.97 and a high of $70.97. As of 11:55, GENZ is trading at $70.09 up $2.09 (3.1%). The chart for GENZ looks bullish and S&P gives GENZ a positive 4 STARS (out of 5) buy ranking.

Continue reading Genzyme Lifted by Takeover Speculation

Options Update: BP Overall Volatility Decreases

Posted Jul 27th 2010 9:00AM by Paul Foster (RSS feed)
Filed under: Johnson and Johnson (JNJ), BP p.l.c. ADS (BP), Options, Genzyme (GENZ)

BP (BP) closed up $1.79 Monday to $38.65. The company reported a $17 billion loss Tuesday morning and announced it has replaced CEO Tony Hayward with Bob Dudley. Overall option implied volatility of 51 is below a level of 78 from June 28, according to Track Data, suggesting decreasing price movement.

Genzyme (GENZ) closed up $4.86 to $67.38. Sanofi-Aventis (SNY), GlaxoSmithKline (GSK) and Johnson & Johnson (JNJ) may be interested in making a play for GENZ, reports the Wall Street Journal. Overall option implied volatility of 40 is above GENZ 26-week average of 31, according to Track Data, suggesting larger price movement.

Update is by Stock Specialist Paul Foster of theflyonthewall.com.

Closing Bell: Bulls Start the Week Off (CBOE, BP, LCC, FDX, VZ, IBM, GENZ)

Posted Jul 26th 2010 4:20PM by Jon Ogg (RSS feed)
Filed under: International Business Machines (IBM), Verizon Communications (VZ), BP p.l.c. ADS (BP), US Airways Group (LCC)

Stocks were set to close almost at the highs of the trading day based upon a continued hope of solid earnings and a mixed housing market picture. Expected news also drove anticipations for the week.

Here were today's unofficial closing bell levels:

Dow Jones 10,525.43 +100.81 (0.97%)
S&P 500 1,115.01 +12.35 (1.12%)
Nasdaq 2,296.43 +26.96 (1.19%)

Top Analyst Calls

Continue reading Closing Bell: Bulls Start the Week Off (CBOE, BP, LCC, FDX, VZ, IBM, GENZ)

ADHD Patch Helps Investors Focus on Shire

Posted Jul 7th 2010 6:00PM by Wade Hansen (RSS feed)
Filed under: Stocks to Buy

The Food and Drug Administration (FDA) recently gave Shire Plc (SHPGY) shareholders something to smile about when it approved Daytrana for treating patients between 13 and 17 years who suffer from Attention Deficit Hyperactivity Disorder (ADHD).

Daytrana is the only ADHD treatment that is available in a transdermal patch, which delivers methylphenidate through the skin into the bloodstream. It is already approved for use by patients between 6 and 12 years.

With this announcement, Shire -- which licensed Daytrana from Noven Pharmaceuticals -- stands to gain market share and increase revenues.

Continue reading ADHD Patch Helps Investors Focus on Shire

Next Page >